The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wahl Bryan since 2022.
This trader's CIK number is 1841401.
At the time of last reporting, Wahl Bryan was the General Counsel of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS).
Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TARS | 0 | $0 | 9,686 | $463,764 | 19,213 | $0 |
| 2024 | TARS | 0 | $0 | 4,436 | $135,741 | 12,038 | $0 |
| 2023 | TARS | 0 | $0 | 10,804 | $167,868 | 33,500 | $0 |
| 2022 | TARS | 0 | $0 | 3,501 | $58,518 | 10,251 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-18 | TARS | Sale | 3,341 | 46.29 | 154,654 |
| 2025-03-19 | TARS | Sale | 3,261 | 47.40 | 154,571 |
| 2025-03-20 | TARS | Sale | 3,084 | 50.11 | 154,539 |
| 2025-03-15 | TARS | Option Ex | 19,213 | .00 | 0 |
| 2024-03-18 | TARS | Sale | 4,436 | 30.60 | 135,741 |
| 2024-03-15 | TARS | Option Ex | 12,038 | .00 | 0 |
| 2023-11-30 | TARS | Sale | 8,356 | 16.31 | 136,286 |
| 2023-11-29 | TARS | Option Ex | 23,920 | .00 | 0 |
| 2023-03-21 | TARS | Sale | 350 | 12.89 | 4,511 |
| 2023-03-22 | TARS | Sale | 357 | 12.64 | 4,512 |
| 2023-03-23 | TARS | Sale | 371 | 12.15 | 4,507 |
| 2023-03-17 | TARS | Sale | 339 | 13.28 | 4,501 |
| 2023-03-20 | TARS | Sale | 357 | 12.61 | 4,501 |
| 2023-03-15 | TARS | Option Ex | 4,790 | .00 | 0 |
| 2023-03-16 | TARS | Sale | 337 | 13.43 | 4,525 |
| 2023-03-15 | TARS | Option Ex | 4,790 | .00 | 0 |
| 2023-03-16 | TARS | Sale | 337 | 13.43 | 4,525 |
| 2022-12-02 | TARS | Sale | 1,154 | 16.90 | 19,502 |
| 2022-11-29 | TARS | Option Ex | 10,251 | .00 | 0 |
| 2022-12-01 | TARS | Sale | 1,164 | 16.75 | 19,497 |
| 2022-11-30 | TARS | Sale | 1,183 | 16.50 | 19,519 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wahl Bryan (General Counsel of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.